Roger N. Farah - 17 Nov 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Roger N. Farah
Issuer symbol
CVS
Transactions as of
17 Nov 2022
Net transactions value
+$305,000
Form type
4
Filing time
21 Nov 2022, 15:55:35 UTC
Previous filing
18 Oct 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 3,821 17 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Share Credits Award $305,000 +3,213 +19% $94.93 20,575 17 Nov 2022 Common Stock 3,213 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
F2 Consists of deferred stock compensation payable pursuant to Reporting Person's election.